Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/16/2022
Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...
3/16/2022
China Resources Licenses Global Rights of Ab Studio's COVID Antibody ...
3/16/2022
PharmCube: An Analysis of NDAs in China
3/16/2022
Another Strike for Biotech: China (Evaluate)
3/15/2022
Biopharma Patents in China: Litigation, Licensing, and Patent Linkage ...
3/14/2022
China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
3/14/2022
Chinese Investors' Interest In Cell And Gene Therapy Remains Strong
3/14/2022
CDE Releases the Draft Guidelines for Clinical Trial of Improvement Ch...
3/11/2022
Pharma CMO Stevanato Group Expands Capacity in China with New Facility
3/11/2022
NMPA Issues the List of Reference Formulations for GQCE Studies (52nd ...
3/11/2022
CDE Solicits Comments on the Draft Procedures for Adjustment of Publis...
3/11/2022
CDE Solicits Comments on the Draft Technical Guidelines for Protocol C...
3/11/2022
CDE Solicits Comments on Two Draft TCM Registration Guidelines
3/11/2022
Recent Executive Moves
3/11/2022
Drug R&D and Product Registration News Digest March 2022 (2)
3/10/2022
AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
3/10/2022
SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...
3/10/2022
Zai Lab Revenue Triples, As It Struggles to Break Cycle of Mounting Lo...
3/9/2022
Snapshot of MNC Pharma's China Performance in 2021 (Updated)
3/9/2022
Lonza Expands API Development and Manufacturing Laboratories in Nansha
3/9/2022
Hanmi to Launch High Blood Pressure Drug Amosartan in China
3/9/2022
China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
3/7/2022
Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...
3/7/2022
Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...
3/7/2022
J&J Reportedly in Talks for Biotech Deals in China
3/7/2022
NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...
3/7/2022
NHC Establishes the Pharmacy Management and Drug Therapy Committee
3/7/2022
Central Government Report Emphasizes on Nine Healthcare Reform Measure...
3/4/2022
Drug R&D and Product Registration News Digest March 2022 (1)
3/4/2022
Recent Executive Moves
Page:
91
/
719
Total number of articles:
21546
:
[First]
[<<]
[89]
[90]
[91]
[92]
[93]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit